Literature DB >> 29263158

Clb6-Cdc28 Promotes Ribonucleotide Reductase Subcellular Redistribution during S Phase.

Xiaorong Wu1, Xiuxiang An1, Caiguo Zhang1,2, Mingxia Huang3,2.   

Abstract

A tightly controlled cellular deoxyribonucleotide (deoxynucleoside triphosphate [dNTP]) pool is critical for maintenance of genome integrity. One mode of dNTP pool regulation is through subcellular localization of ribonucleotide reductase (RNR), the enzyme that catalyzes the rate-limiting step of dNTP biosynthesis. In Saccharomyces cerevisiae, the RNR small subunit, Rnr2-Rnr4, is localized to the nucleus, whereas the large subunit, Rnr1, is cytoplasmic. As cells enter S phase or encounter DNA damage, Rnr2-Rnr4 relocalizes to the cytoplasm to form an active holoenzyme complex with Rnr1. Although the DNA damage-induced relocalization requires the checkpoint kinases Mec1-Rad53-Dun1, the S-phase-specific redistribution does not. Here, we report that the S-phase cyclin-cyclin-dependent kinase (CDK) complex Clb6-Cdc28 controls Rnr2-Rnr4 relocalization in S phase. Rnr2 contains a consensus CDK site and exhibits Clb6-dependent phosphorylation in S phase. Deletion of CLB6 or removal of the CDK site results in an increased association of Rnr2 with its nuclear anchor Wtm1, nuclear retention of Rnr2-Rnr4, and an enhanced sensitivity to the RNR inhibitor hydroxyurea. Thus, we propose that Rnr2-Rnr4 redistribution in S phase is triggered by Clb6-Cdc28-mediated phosphorylation of Rnr2, which disrupts the Rnr2-Wtm1 interaction and promotes the release of Rnr2-Rnr4 from the nucleus.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  S phase; cyclin-dependent kinases; cyclins; deoxyribonucleotides; nucleocytoplasmic transport; ribonucleotide reductase

Mesh:

Substances:

Year:  2018        PMID: 29263158      PMCID: PMC5829487          DOI: 10.1128/MCB.00497-17

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

Review 1.  How do Cdc7 and cyclin-dependent kinases trigger the initiation of chromosome replication in eukaryotic cells?

Authors:  Karim Labib
Journal:  Genes Dev       Date:  2010-06-15       Impact factor: 11.361

2.  Constitutively high dNTP concentration inhibits cell cycle progression and the DNA damage checkpoint in yeast Saccharomyces cerevisiae.

Authors:  Andrei Chabes; Bruce Stillman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

Review 3.  Getting started: regulating the initiation of DNA replication in yeast.

Authors:  W M Toone; B L Aerne; B A Morgan; L H Johnston
Journal:  Annu Rev Microbiol       Date:  1997       Impact factor: 15.500

4.  Two genes differentially regulated in the cell cycle and by DNA-damaging agents encode alternative regulatory subunits of ribonucleotide reductase.

Authors:  S J Elledge; R W Davis
Journal:  Genes Dev       Date:  1990-05       Impact factor: 11.361

Review 5.  Deoxyribonucleotide metabolism, mutagenesis and cancer.

Authors:  Christopher K Mathews
Journal:  Nat Rev Cancer       Date:  2015-09       Impact factor: 60.716

Review 6.  Choosing the right metal: case studies of class I ribonucleotide reductases.

Authors:  Mingxia Huang; Mackenzie J Parker; JoAnne Stubbe
Journal:  J Biol Chem       Date:  2014-08-26       Impact factor: 5.157

7.  An overview of Cdk1-controlled targets and processes.

Authors:  Jorrit M Enserink; Richard D Kolodner
Journal:  Cell Div       Date:  2010-05-13       Impact factor: 5.130

8.  The DNA replication and damage checkpoint pathways induce transcription by inhibition of the Crt1 repressor.

Authors:  M Huang; Z Zhou; S J Elledge
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

9.  Dif1 controls subcellular localization of ribonucleotide reductase by mediating nuclear import of the R2 subunit.

Authors:  Xiaorong Wu; Mingxia Huang
Journal:  Mol Cell Biol       Date:  2008-10-06       Impact factor: 4.272

10.  A suppressor of two essential checkpoint genes identifies a novel protein that negatively affects dNTP pools.

Authors:  X Zhao; E G Muller; R Rothstein
Journal:  Mol Cell       Date:  1998-09       Impact factor: 17.970

View more
  2 in total

1.  SiRNA-Mediated RRM2 Gene Silencing Combined with Cisplatin in the Treatment of Epithelial Ovarian Cancer In Vivo: An Experimental Study of Nude Mice.

Authors:  Ting Xue; Liming Wang; Yong Li; Hao Song; Huijun Chu; Hongjuan Yang; Ailian Guo; Jinwen Jiao
Journal:  Int J Med Sci       Date:  2019-10-21       Impact factor: 3.738

2.  Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Kiavash Hushmandi; Farid Hashemi; Ebrahim Rahmani Moghadam; Mehdi Raei; Mahshad Kalantari; Shima Tavakol; Reza Mohammadinejad; Masoud Najafi; Franklin R Tay; Pooyan Makvandi
Journal:  ACS Comb Sci       Date:  2020-10-23       Impact factor: 3.784

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.